The Gross Margin of Lyell Immunopharma Inc (LYEL) is 7775.20%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 7775.20% |